Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-20

Clinical Trial Update: A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating primary retroperitoneal lymph node dissection in patients with testicular cancer and limited retroperitoneal metastases; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Western University, Canada | Conditions: Testicular Cancer | Phase 2 | Status: RECRUITING